Streck Fusion2新型混合塑料采血管論文
Streck cfDNA采血管液體活檢應(yīng)用表現(xiàn)
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
Inga Medina Diaz, Annette Nocon, Daniel H. Mehnert, Johannes Fredebohm, Frank Diehl , Frank Holtrup
Published: November 10, 2016https://doi.org/10.1371/journal.pone.0166354
摘要
目的
液體活檢的廣泛應(yīng)用對(duì)室溫運(yùn)送血液樣本提出了更高要求,采血管需要保持游離DNA的數(shù)量和穩(wěn)定,防止循環(huán)腫瘤DNA被基因組DNA稀釋。通過(guò)高靈敏度突變檢測(cè)技術(shù)評(píng)估Streck Cell-Free DNA BCT采血管對(duì)細(xì)胞和DNA穩(wěn)定性的保護(hù)。
方法
靜脈血樣分別用Streck Cell-Free DNA BCT和標(biāo)準(zhǔn)K2EDTA管采集。提取DNA之前采血管分別在不同溫度儲(chǔ)存。提取后的游離DNA進(jìn)行qPCR,BEAMing和 Plasma Safe-Sequencing (Safe-SeqS)分析。
結(jié)果
用Streck Cell-Free DNA BCT采集的健康血樣室溫存儲(chǔ)5天后,并不影響DNA產(chǎn)量和突變水平。
結(jié)論
使用Streck Cell-Free DNA BCT采集運(yùn)送的全血可以用于下游液體活檢(BEAMing和 Safe-SeqS)。由于運(yùn)送溫度是重要影響因素,要獲得可靠的突變結(jié)果需要特別注意保持室溫在限定范圍內(nèi)。
Objectives
Making liquid biopsy testing widely available requires a concept to ship whole blood at ambient temperatures while retaining the integrity of the cell-free DNA (cfDNA) population and stability of blood cells to prevent dilution of circulating tumor DNA (ctDNA) with wild-type genomic DNA. The cell- and DNA-stabilizing properties of Streck Cell-Free DNA BCT blood collection tubes (cfDNA BCTs) were evaluated to determine if they can be utilized in combination with highly sensitive mutation detection technologies.
Methods
Venous blood from healthy donors or patients with advanced colorectal cancer (CRC) was collected in cfDNA BCTs and standard K2EDTA tubes. Tubes were stored at different temperatures for various times before plasma preparation and DNA extraction. The isolated cfDNA was analyzed for overall DNA yield of short and long DNA fragments using qPCR as well as for mutational changes using BEAMing and Plasma Safe-Sequencing (Safe-SeqS).
Results
Collection of whole blood from healthy individuals in cfDNA BCTs and storage for up to 5 days at room temperature did not affect the DNA yield and mutation background levels (n = 60). Low-frequency mutant DNA spiked into normal blood samples as well as mutant circulating tumor DNA in blood samples from CRC patients collected in cfDNA BCTs were reliably detected after 3 days of storage at room temperature. However, blood samples stored at ≤ 10°C and at 40°C for an extended period of time showed elevated normal genomic DNA levels and an abnormally large cellular plasma interface as well as lower plasma volumes.
Conclusion
Whole blood shipped in cfDNA BCTs over several days can be used for downstream liquid biopsy testing using BEAMing and Safe-SeqS. Since the shipping temperature is a critical factor, special care has to be taken to maintain a defined room temperature range to obtain reliable mutation testing results.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
歡迎您致電 重慶市華雅干細(xì)胞技術(shù)有限公司 為您提供Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT Fusion2 第二代升級(jí)新型混合塑料采血管現(xiàn)貨 , 華雅干細(xì)胞-:
Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT 第二代升級(jí)新型混合塑料采血管
Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT 第二代升級(jí)新型混合塑料采血管是一種特制混合塑料的新型采血管。特制保存劑能穩(wěn)定有核血細(xì)胞,防止細(xì)胞基因組DNA的釋放,保留血漿游離循環(huán)DNA和循環(huán)腫瘤細(xì)胞(CTC),保證游離DNA的高品質(zhì)分離。
產(chǎn)品訂購(gòu)信息-Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT 第二代升級(jí)新型混合塑料采血管
品牌 | 貨號(hào) | 產(chǎn)品描述 |
Streck | 230252 | 6-Tube Pack (9 mL) Hybrid Plastic, RUO |
Streck | 230253 | 100-Tube Box (9 mL) Hybrid Plastic, RUO |
Streck | 230254 | 1000-Tube Box (9 mL) Hybrid Plastic, RUO |
Streck | 230255 | 6-Tube Pack (9 mL) Hybrid Plastic, CE |
Streck | 230256 | 100-Tube Box (9 mL) Hybrid Plastic, CE |
Streck | 230257 | 1000-Tube Box (9 mL) Hybrid Plastic, CE |
RUO:Research Use Only
歡迎您致電 重慶市華雅干細(xì)胞技術(shù)有限公司 為您提供Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT Fusion2 第二代升級(jí)新型混合塑料采血管現(xiàn)貨 , 華雅干細(xì)胞-:
Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT 第二代升級(jí)新型混合塑料采血管,Streck Cell-Free DNA BCT Blood Collection Tube 218976, 218962基因無(wú)創(chuàng)管,唐氏無(wú)創(chuàng)篩查采血管,游離DNA采血管,游離RNA采血管,循環(huán)腫瘤細(xì)胞(circulating tumor cell)CTC采血管 華雅再生醫(yī)學(xué) 現(xiàn)貨供應(yīng)
華雅干細(xì)胞 現(xiàn)貨供應(yīng):美國(guó)Streck 218962 Cell-Free DNA BCT Blood Collection Tube DNA基因檢測(cè)無(wú)創(chuàng)采血管和美國(guó)Streck 218976 Cell-Free RNA BCT Blood Collection Tube基因檢測(cè)無(wú)創(chuàng)采血管 規(guī)格:100管/盒,應(yīng)用于:唐氏無(wú)創(chuàng)篩查采血管,游離DNA采血管,游離RNA采血管等等。華雅干細(xì)胞 現(xiàn)貨供應(yīng):BD 362761 Vacutainer® CPT™ Cell Preparation Tube 肝素鈉單核細(xì)胞制備管/采血管,60支/盒。
提供產(chǎn)品:華雅干細(xì)胞致力于為中國(guó)干細(xì)胞領(lǐng)域的干細(xì)胞科學(xué)研究、臍帶血/造血干細(xì)胞/臍帶/脂肪/胎盤干細(xì)胞庫(kù)、干細(xì)胞臨床轉(zhuǎn)化醫(yī)學(xué)、干細(xì)胞美容及干細(xì)胞抗衰老、免疫細(xì)胞治療、T細(xì)胞治療、臨床干細(xì)胞治療等再生醫(yī)學(xué)和個(gè)體化治療產(chǎn)業(yè)鏈的相關(guān)客戶提供:MSC間充質(zhì)干細(xì)胞培養(yǎng)基、iPS/ES胚胎干細(xì)胞培養(yǎng)基、血清替代物、羊水培養(yǎng)基、基底膜基質(zhì)膠細(xì)胞支架、干細(xì)胞生長(zhǎng)分化調(diào)控因子、BioMarker 流式檢測(cè)抗體、支原體檢測(cè)試劑盒、內(nèi)毒素檢測(cè)試劑盒、干細(xì)胞存儲(chǔ)細(xì)胞凍存袋、細(xì)胞培養(yǎng)瓶、USP級(jí)DMSO二甲基亞砜細(xì)胞凍存液、細(xì)胞培養(yǎng)相關(guān)試劑耗材儀器等種類豐富的產(chǎn)品,以“Focus on improving the quality of Stem Cells專注干細(xì)胞研究,提升干細(xì)胞品質(zhì)”為己任,我們與客戶攜手為中國(guó)干細(xì)胞產(chǎn)業(yè)的發(fā)展而前行。
歡迎您致電 重慶市華雅干細(xì)胞技術(shù)有限公司 為您提供Streck 230253 9mL Hybrid Plastic Cell-Free DNA BCT Fusion2 第二代升級(jí)新型混合塑料采血管現(xiàn)貨 , 華雅干細(xì)胞-:
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來(lái)源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來(lái)源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來(lái)源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點(diǎn)和對(duì)其真實(shí)性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個(gè)人從本網(wǎng)轉(zhuǎn)載時(shí),必須保留本網(wǎng)注明的作品第一來(lái)源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問(wèn)題,請(qǐng)?jiān)谧髌钒l(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。